Neuroscience

Study identifies new concepts for GLP-1 action in the brain

Researcher Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named the 2023 breakthrough of the year by the Science Magazine. Not only have millions of people ...

Diseases, Conditions, Syndromes

'We need to know': WHO says China has more on COVID origin

The World Health Organization said Thursday it was sure China had far more data that could shed light on the origins of COVID, demanding Beijing immediately share all relevant information.

Oncology & Cancer

Immunotherapy is new revolution in cancer fight

Immunotherapy has made great strides against cancers like melanoma that were once believed incurable, though scientists still do not understand why it works well in some cases but not others.

Health

Research backlog at NIH due to shutdown

(HealthDay)—It will take some time before research programs return to normal at the U.S. National Institutes of Health after the end of the federal government shutdown, officials say.

page 2 from 2